Melphalan Chemoreduction for Ocular Melanoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Uveal Melanoma
Related studies linked through entity extraction aliases.
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
- Status
- UNKNOWN
- Phase
- N/A
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Retrospective Register for Uveal Melanoma
- Status
- RECRUITING
- Phase
- N/A
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adjuvant Melatonin for Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
- Status
- WITHDRAWN
- Phase
- PHASE2
Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp
- Status
- AVAILABLE
- Phase
- N/A
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Status
- RECRUITING
- Phase
- N/A
Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)
- Status
- COMPLETED
- Phase
- NA
Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2